Relievant Medsystems has raised $58m through a Series E equity financing round.
New investor RK Mellon and existing investors New Enterprise Associates, Canaan Ventures, Morgenthaler, and Emergent Ventures also participated in the funding round.
Relievant Medsystems plans to use the funds to complete patient enrolment for its INTRACEPT study, which is the company’s second Level I randomised controlled trial.
Based in the US, Relievant Medsystems is a medical device company that provides solutions for patients with chronic axial low back pain.
Swiss drug delivery devices developer Sensile Medical has signed a collaboration agreement with Sanofi and Verily.
The collaboration will focus on the development and commercialisation of a new generation of all-in-one pre-filled insulin patch pump, for patients with type 2 diabetes.
Sanofi is a French pharmaceutical company, while Verily is a research and life sciences company based in the US.
Senseonics Holdings has raised $130m through an underwritten public offering of shares of its common stock.
The underwriters will receive a 30-day option to buy additional shares worth $19.5m.
Cooley was appointed as legal adviser for the offering, which is scheduled to close this month subject to customary closing conditions.
Based in the US, Senseonics Holdings is a medical technology company that develops continuous glucose monitoring (CGM) systems.
The company plans to use the funds towards the development and commercialisation of its Eversense CGM System, as well as working capital and other general corporate needs.
Mensia Technologies has raised €1.3m ($1.5m) in a funding round led by Health-Angels Rhone-Alpes (HARA), BPI de Rennes and existing shareholders.
Based in France, Mensia Technologies is a medical device company engaged in the development of non-invasive medical devices for the treatment of central nervous system disorders.
The company plans to use the funds for the introduction of its koala neurofeedback as a novel medical device in Europe.
Mercator MedSystems has raised $11m through a Series D equity financing round from Shenzhen Salubris Pharmaceuticals Co. (Salubris).
The funding round also included the participation of Mercator investors and other undisclosed new investors.
Salubris has gained the exclusive rights to commercially develop and manufacture Mercator’s micro-infusion device Bullfrog in China, as part of the transaction.
Mercator MedSystems is a US-based medical device company that develops catheter-guided micro-fluid injection systems, while Salubris is a Chinese biotechnology company that develops novel therapeutics for medical applications.
Mercator plans to use the funds towards the clinical development of its proprietary micro-infusion catheter systems.
Establishment Labs (Establishment Labs Holdings) has filed a registration statement with the US Securities and Exchange Commission (SEC) to raise $57.5m through an initial public share offering.
The proceeds are intended to be used to fund a PMA study to gain approval and market the company’s Motiva implants in the US.
Part of the funds will also be used for the debt repayment, working capital and other general corporate needs.
Wilson Sonsini Goodrich & Rosati and Conyers Dill & Pearman were appointed as legal advisers to the company for the offering.
Based in Costa Rica, Establishment Labs is a medical device company that develops and markets silicone-filled breast and body-shaping implants.
Stryker Corporation has entered an agreement to acquire SafeAir for an undisclosed sum.
The transaction is expected to be closed in the fourth quarter of 2018, subject to customary closing conditions.
Based in the US, Stryker Corporation is a medical technology company engaged in the manufacture of orthopaedic implants and surgical equipment, while SafeAir is a Switzerland-based medical device firm that designs and develops novel surgical smoke evacuation solutions.
The acquisition will enable Stryker to expand its smoke evacuation portfolio in the US and Europe.
Ergon Capital Partners III has signed an agreement to purchase a controlling interest in Indo Optical SLU from Sherpa Capital Entidad Gestora SGEIC S.A for an undisclosed sum.
Sherpa will retain a minority interest in Indo Optical along with Ergon, Oquendo III (SCA) SICAR and management.
Based in Belgium, Ergon Capital is a private equity firm, while Indo Optical is a Spanish ophthalmic lens and equipment manufacturer.
Resonetics has completed the acquisition of Medelec for an undisclosed consideration.
Medelec will continue to operate under its own brand until October, after which it will be renamed as Resonetics Switzerland.
Based in the US, Resonetics is a provider of medical device components, while Medelec is a Swiss medical device company that produces and sells metal tubing components.